Share This

Public company info - SciClone Pharmaceuticals (Holdings) Limited , 06600.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

SciClone Pharmaceuticals (Holdings) Limited, 06600.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities 1,268,804 1,213,580 1,031,590 1,046,547 349,181 166,684
Net Cash Flow from Return on Investments & Servicing of Finance -223,646 -867,206 -2,187,103 -200,821 -558,936 5,778
　Interest Received 28,762 7,958 8,577 11,964 6,225 7,522
　Interest Paid -46,786 -47,861 -21,922 -212,785 -565,161 -1,744
　Dividend Received 0 0 0 0 0 0
　Dividend Paid -205,622 -827,303 -2,173,758 0 0 0
　Others 0 0 0 0 0 0
Taxes (Paid) / Refunded -67,212 -144,221 -37,278 -25,696 -182,657 -12,611
Net Cash Flow from Investing Activities -1,025,549 -126,237 -670,629 -152,490 171,145 -10,728
　Additions to Fixed Assets -5,768 -5,700 -3,747 -1,947 -12,447 -6,293
　Disposal of Fixed Assets 448 272 0 0 0 0
　Increase in Investments -673,588 -1,134,412 -1,060,980 -626,976 -13,726 0
　Decrease in Investments 531,712 1,109,326 1,022,840 507,128 127,455 0
　Net Cash Flow with Related Parties 0 0 0 0 45,347 0
　Others -878,353 -95,723 -628,742 -30,695 24,516 -4,435
Net Cash Flow before Financing Activities -47,603 75,916 -1,863,420 667,540 -221,267 149,123
Net Cash Flow from Financing Activities -464,640 942,872 2,120,418 -22,993 20,790 -476,526
　New Loans 0 0 2,123,850 0 0 0
　Loans Repayment -447,812 -788,123 -19,283 -22,993 -24,557 -23,948
　Fixed Income/Debt Instruments 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0
　Equity Financing 16,005 1,734,174 21,452 0 0 19,169
　Net Cash Flow with Related Parties 0 0 0 0 45,347 0
　Others -32,833 -3,179 -5,601 0 0 -471,747
Increase(Decrease) in Cash & Cash Equivalents -512,243 1,018,788 256,998 644,547 -200,477 -327,403
Cash & Cash Equivalents at Beginning of Year 2,127,488 1,118,986 919,490 275,962 481,629 795,633
Net Cash Flow due to Change in Exchange Rate/Others 56,584 -10,286 -57,502 -1,019 -5,190 13,399
Cash & Cash Equivalents at End of Year 1,671,829 2,127,488 1,118,986 919,490 275,962 481,629
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.